News

Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.
The FDA has issued a complete response letter to Telix Pharmaceuticals regarding TLX101-CDx for the imaging of gliomas.
New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...
A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...
Memphis Grizzlies players and coaches huddled together for a prayer inside a silent Spectrum Center Arena on Tuesday night against the Charlotte Hornets after rookie forward Jaylen Wells was ...
During the late 1980s, advancements in computer technology and imaging allowed identification ... Such examples include many advanced head and neck cancers, where the targets are anterior and ...
His story is raising awareness for this National Head and Neck Cancer Awareness Month. It’s estimated nearly 70,000 new cases of head and neck cancer will be diagnosed this year. Brandon ...
selective cancer therapies. Studying essential, dynamic processes such as DNA replication requires conditional, time-resolved genetics. The Lemmens group develops and combines innovative protein ...
Head and neck cancer symptoms vary by tumor location, often presenting as a neck lump or voice changes. Smoking and HPV are major risk factors; cessation and vaccination are crucial preventive ...
Results of a study show convergent genetic adaptation under hypoxia (lack of ... of oxygen-starved cancer cells. The study was directed by Rodrigo Toledo, Head of the Vall d'Hebron Institute ...
Attribution (BY): Credit must be given to the creator. Molecular imaging has emerged as a transformative tool in cancer diagnosis, enabling the visualization of biological processes at the cellular ...
“Protons cannot effectively treat deep-seated tumours, like some developed in the lungs. Their primary use has been for paediatric cancers, adult head and neck cancers, and brain tumours,” Parsons ...